Protocol Details
Diagnosis and Treatment of Patients with Cystic Fibrosis
This study is NOT currently recruiting participants.
Summary
Number |
87-DK-0029 |
Sponsoring Institute |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Recruitment Detail |
Type: No longer recruiting/follow-up only
Gender: Male & Female
Min Age: 4 Years
Max Age: 120 Years |
Referral Letter Required |
No |
Population Exclusion(s) |
None |
Keywords |
Cystic Fibrosis;
Pancreatic Insufficiency;
Bronchiectasis;
Liver Disease;
Natural History |
Recruitment Keyword(s) |
None |
Condition(s) |
Cystic Fibrosis;
Liver Disease or Abnormalities;
Diabetes;
Pancreatic Insufficiency (Exocrine and Endocrine) |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
National Institute of Diabetes and Digestive and Kidney Diseases |
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
Eligibility
INCLUSION CRITERIA
- Patients with known or suspected CF and family members of patients with CF.
- >=4 years of age
EXCLUSION CRITERIA
-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
Citations:
Not Provided
Contacts:
Clinical Trials Number:
NCT00001223